Latest MRSA Stories
WALTHAM, Mass., June 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the uptake of two emerging agents from Forest/AstraZeneca/Takeda and Trius will drive the methicillin-resistant Staphylococcus aureus (MRSA) drug market to increase from $631 million in 2009 to $752 million in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The Pharmacor 2010 findings...
An outbreak of infection due to linezolid and methicillin-resistant StaphylococcuS aureus (LRSA) in 12 intensive care unit patients in Spain was associated with transmission within the hospital and extensive usage of the antibiotic linezolid, often used for the treatment of serious infections, with reductions in linezolid use and infection-control measures associated with resolution of the outbreak.
A study recently published has found that the number of children hospitalized with dangerous drug-resistant staph infections surged 10-fold in recent years.
CHICAGO, May 11 /PRNewswire-USNewswire/ -- More Americans die annually from invasive methicillin-resistant Staphylococcus aureus (MRSA) infections than from HIV/AIDS, H1N1 influenza and Parkinson's disease, yet the United States and many other countries' health officials continue to ignore the global crisis. (Logo: http://www.newscom.com/cgi-bin/prnh/20090825/DC65136LOGO) "Everyone knows someone who has been affected by MRSA," states founder Jeanine Thomas, a survivor of MRSA, sepsis and C.
HIV-infected patients are at a markedly increased risk for community acquired Methicillin-resistant Staphylococcus aureus (CA-MRSA) infections.
Bathing trauma patients daily using cloths containing the antiseptic chlorhexidine may be associated with a decreased rate of colonization and infection by methicillin-resistant Staphylococcus aureus (MRSA) and other difficult-to-treat bacteria
KETTERING, Ohio, March 15 /PRNewswire/ -- Kettering Health Network is the nation's first health system to use a new testing process developed by DIATHERIX Laboratories (www.DIATHERIX.com), which dramatically reduces the time it takes to detect H1N1, methicillin resistant staphylococcus (MRSA), Clostridium difficile (C-diff) and other infectious diseases.
TAIPEI, Taiwan, March 12 /PRNewswire-Asia/ -- TaiGen Biotechnology Co., Ltd. announced today the Phase II trial of nemonoxacin (TG-873870) in Diabetic Foot Infection (DFI) with once-a-day dosing met the primary endpoints and showed promising clinical efficacy and good tolerability.
Drug-resistant bacteria infections have increased by 90 percent in the US since 1999, and new strains have been discovered outside of hospitals, according to researchers.
CHICAGO, Oct. 6 /PRNewswire-USNewswire/ -- The Chicago-based non-profit organization, MRSA Survivors Network launched the first inaugural World MRSA Day event on Oct. 1st at Loyola University Chicago with great success. MRSA activists came from across the U.S.